Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Blood|May 1, 1996
A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapyM S Gordon, W J McCaskill-Stevens, L A Battiato, et al.Genomics|March 15, 1996
Alternatively spliced exons encode the tissue-specific 5' termini of leukocyte pp52 and stromal cell S37 mRNA isoformsA A Thompson, S A Omori, M J Gilly, et al.Oncogene|May 17, 2006
Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosisH Chen, M Li, R A Campbell, et al.Photochemistry and Photobiology|September 8, 2001
Identification of a vibrational frequency corresponding to H-atom translocation in hypericinB M Showalter, A Datta, P K Chowdhury, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trialsL E Flaherty, M Atkins, J Sosman, et al.ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.Blood|May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trialC H Moskowitz, P Stiff, M S Gordon, et al.Nano Letters|September 11, 2013
Giant piezoresistive on/off ratios in rare-earth chalcogenide thin films enabling nanomechanical switchingM Copel, M A Kuroda, M S Gordon, et al.Human Genetics|September 1, 2018
Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel diseaseE R Schiff, M Frampton, N Ben-Yosef, et al.Pageof 10